Product name:Vandetanib
CAS: 443913-73-3
Molecular Formula: C22H24BrFN4O2
Molecular Weight: 475.35
Product description:A synthesis of aniline quinazoline compounds, for oral small molecule targets more butyric acid kinase inhibitor (TKI), at the same time acting on tumor cells of EGFR and VEGFR and RET tyrosine kinase, still can selectively inhibit other tyrosine kinase, and serine/threonine kinase, multiple targets joint block signaling, therefore is a kind of multi-channel tumor signal transduction inhibitors.